ConductScience.org, home

Paper · 19787747

High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.

Srivastava NK and 3 others. NMR Biomed, 2010. Cited by 59 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance. Papers, record 19787747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19787747

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.
PubMed
Journal
NMR Biomed
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
1.84
iCite
Revised in PubMed
2015-11-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Srivastava NKNiraj Kumar
2Pradhan SSunil
3Mittal BBalraj
4Gowda GAG A Nagana

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lipid MetabolismMajor topic
LipidsMajor topic
Magnetic Resonance SpectroscopyMajor topic
Muscular Dystrophy, DuchenneMajor topic
Adolescent
Child
Child, Preschool
Dystrophin
Electromyography
Humans
Muscle, Skeletal

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
42,298,331Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients.J Cachexia Sarcopenia Muscle2026https://conductscience.org/library/papers/42298331PubMed
41,906,416Metabolic Complications and Ultrasound-Detected Liver Abnormalities in Paediatric Patients With Duchenne Muscular Dystrophy.Pediatr Obes2026https://conductscience.org/library/papers/41906416PubMed
41,869,723DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.JCI Insight2026https://conductscience.org/library/papers/41869723PubMed
41,369,776Mechanism-based new approach methodologies for in vitro detection of chemical-induced liver steatosis.Arch Toxicol2026https://conductscience.org/library/papers/41369776PubMed
40,490,739Association between triglycerides and remnant cholesterol levels and spine bone mineral density in Duchenne muscular dystrophy.Lipids Health Dis2025https://conductscience.org/library/papers/40490739PubMed
39,716,324Comparative lipidomic and metabolomic profiling of mdx and severe mdx-apolipoprotein e-null mice.Skelet Muscle2024https://conductscience.org/library/papers/39716324PubMed
39,138,561Apolipoprotein E knockout, but not cholesteryl ester transfer protein (CETP)-associated high-density lipoprotein cholesterol (HDL-C) lowering, exacerbates muscle wasting in dysferlin-null mice.Lipids Health Dis2024https://conductscience.org/library/papers/39138561PubMed
37,574,742Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective.J Neuromuscul Dis2023https://conductscience.org/library/papers/37574742PubMed
37,182,897Dyslipidemia in Muscular Dystrophy: A Systematic Review and Meta-Analysis.J Neuromuscul Dis2023https://conductscience.org/library/papers/37182897PubMed
36,447,272Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.Skelet Muscle2022https://conductscience.org/library/papers/36447272PubMed

1 to 10 of 32

See all 32 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19787747

GET https://conductscience.org/api/papers/v1/19787747/cited_by?page=2